---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-027108"
form_type: "8-K"
ticker: "ELVN"
cik: "0001672619"
company_name: "Enliven Therapeutics, Inc."
filed_at: "2022-07-29T23:59:59+00:00"
generated_at: "2026-06-24T06:59:49.632589+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Imara terminates Boston office lease early; pays $315k fee to reduce costs while exploring strategic alternatives

## Summary
- Terminated 9,236 sq ft office lease set to expire March 2027; termination contingent on landlord finding a new tenant.
- Paid one-time termination fee of $315,000; Landlord may draw $175k existing letter of credit plus $140k cash.
- Early termination intended to reduce operating expenses amid ongoing comprehensive strategic review to maximize stockholder value.
- If no new lease executed within 30 days, or landlord terminates, agreement is void and partial termination fee returned.

## SEC filing metadata
- accession: 0001564590-22-027108
- form_type: 8-K
- ticker: ELVN
- cik: 0001672619
- company_name: Enliven Therapeutics, Inc.
- filed_at: 2022-07-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1672619/000156459022027108/0001564590-22-027108-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1672619/000156459022027108/imra-8k_20220725.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-027108
- JSON: https://secwatch.observer/filing/0001564590-22-027108.json
- Plain text: https://secwatch.observer/filing/0001564590-22-027108.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.